财经
Pfizer's revenue falls again
Strong competition for biosimilars hurt sales of the drug maker's rheumatoid arthritis treatment, Enbrel. Fred Katayama reports.
财经
for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up